Antoni Ribas, MD, PhD

Professor of Medicine
University of California Los Angeles, Los Angeles, CA, USA, United States

Presentation(s):

• 57: Neoadjuvant Pembrolizumab in Stage II-III Desmoplastic Melanoma (SWOG S1512): Surgical Considerations

  Friday, March 24, 2023
  10:24 AM – 10:34 AM

  Disclosure information not submitted.

• 53: Surgical Outcomes of SWOG1801: Neoadjuvant/adjuvant versus adjuvant pembrolizumab for resectable stage III-IV melanoma

  Friday, March 24, 2023
  1:25 PM – 1:37 PM

  Disclosure information not submitted.